Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-28

Clinical Trial Update: Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating induction chemotherapy followed by cetuximab and radiation for HPV-associated resectable stage III/IV oropharyngeal cancer completed; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetuximab (cetuximab)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Head and Neck Cancer, Precancerous Condition | Phase 2 | Status: COMPLETED | Results posted: 2015-10-28